AMPH FY 2022 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMPHAmphastar Pharmaceuticals, Inc.

$894M

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$499M+14.0% YoY

Gross Profit

$249M49.9% margin

Operating Income

$107M21.5% margin

Net Income

$91M18.3% margin

EPS (Diluted)

$1.74

Cash Flow

Operating Cash Flow

$89M

Free Cash Flow

$65M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$742M

Total Liabilities

$213M

Stockholders' Equity

$529M

Cash & Equivalents

$156M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$499M	$438M	+14.0%
Gross Profit	$249M	$200M	+24.6%
Operating Income	$107M	$70M	+53.8%
Net Income	$91M	$62M	+47.1%